Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 065055

Expand all

DOXYCYCLINE (DOXYCYCLINE)
EQ 50MG BASE
Marketing Status: Prescription

Active Ingredient: DOXYCYCLINE
Proprietary Name: DOXYCYCLINE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A065055
Product Number: 001
Approval Date: Dec 1, 2000
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

DOXYCYCLINE (DOXYCYCLINE)
EQ 100MG BASE
Marketing Status: Prescription

Active Ingredient: DOXYCYCLINE
Proprietary Name: DOXYCYCLINE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A065055
Product Number: 002
Approval Date: Dec 1, 2000
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

DOXYCYCLINE (DOXYCYCLINE)
EQ 150MG BASE
Marketing Status: Prescription

Active Ingredient: DOXYCYCLINE
Proprietary Name: DOXYCYCLINE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A065055
Product Number: 003
Approval Date: Jul 15, 2005
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

DOXYCYCLINE (DOXYCYCLINE)
EQ 75MG BASE
Marketing Status: Discontinued

Active Ingredient: DOXYCYCLINE
Proprietary Name: DOXYCYCLINE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A065055
Product Number: 004
Approval Date: Apr 18, 2005
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information